Latest Recombinant proteins Stories
LONDON and BOSTON, November 20, 2014 /PRNewswire/ -- Project to develop first-in-class selective and orally available GLP-1 receptor antagonist for treating severe
DALLAS, November 19, 2014 /PRNewswire/ -- RnRMarketResearch.com adds China Recombinant Protein Drug Industry Report, 2014-2017 market research that says during 2005-2013,
The key factors that are expected to spur the growth of this market are the rising global diabetic population, favorable reimbursement scenario in North America and Europe.
Surveyed German Nephrologists Report that the Majority of Their Patients Treated with Epoetin Alfa Receive a Biosimilar, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Once-weekly treatment for adults with type 2 diabetes comes in a pen with a no-see, no-handle needle INDIANAPOLIS, Nov.
DALLAS, November 1, 2014 /PRNewswire/ -- LifeScienceIndustryResearch.com adds latest insulin pumps market research reports to its store.
Forgetting to turn a clock back this weekend can be a minor inconvenience for most people, but forgetting about the changeover from Daylight Savings Time can be very dangerous for some patients with diabetes.
NovoFine® Plus is the shortest and thinnest pen needle in the Novo Nordisk family of needles designed for diabetes pens PLAINSBORO, N.J., Oct.
- Having a loud voice; vociferous; clamorous.
- Of grand or imposing sound.